Microbiology and Infectious Disease; An Introduction to… series

Session 2 of 4

This session will provide an overview of the role of pharmacokinetic and pharmacodynamics properties in optimising antimicrobial therapy.  This session provides attendees with the essential skills required for understanding some of the key pharmacokinetic properties of antimicrobials and how these can be used to deliver effective therapy at the site of infection.

This series is ideal for antimicrobial pharmacists starting out in this speciality, non-specialists and newly qualified pharmacists with an interest in antimicrobial stewardship.

Many of the concepts will focus on the management of infection in hospital setting but the principles and content are universal to all aspects of healthcare provision including community, clinic and non-acute settings.

The aim of this session is to introduce attendees to the basic concepts of phenotypic and genotypic resistance mechanisms, the national resistance profile and the role of PK/PD properties of antimicrobials and the importance in optimising dosing and administration for better patient outcomes.

After this webinar, attendees should be able to:

• Define the key PK/PD properties of common antimicrobials
• Discuss the importance of MIC values of pathogens and how that influences treatment options
• Define and describe how antimicrobial doses and administrations can be improved to increase bactericidal activity
• Review the common resistant mechanisms and their frequency in the UK population

Speakers
Stephen Hughes, Consultant Antimicrobial Pharmacist, Chelsea and Westminster Healthcare NHS Foundation Trust
Dr Sara Boyd, Infection Specialist Registrar, Guy’s and St Thomas’ NHS Foundation Trust